Sol-Gel SLGL Stock
Sol-Gel Price Chart
Sol-Gel SLGL Financial and Trading Overview
| Sol-Gel stock price | 81.99 USD |
| Previous Close | 82.73 USD |
| Open | 83.27 USD |
| Bid | 81.2 USD x 100 |
| Ask | 82.3 USD x 100 |
| Day's Range | 81.54 - 83.49 USD |
| 52 Week Range | 12.5 - 97.97 USD |
| Volume | 19.78K USD |
| Avg. Volume | 35.78K USD |
| Market Cap | 269.97M USD |
| Beta (5Y Monthly) | 1.158 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 193 USD |
SLGL Valuation Measures
| Enterprise Value | 216.91M USD |
| Trailing P/E | N/A |
| Forward P/E | -10.213628 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 14.6208515 |
| Price/Book (mrq) | 5.2903023 |
| Enterprise Value/Revenue | 11.747 |
| Enterprise Value/EBITDA | -94.308 |
Trading Information
Sol-Gel Stock Price History
| Beta (5Y Monthly) | 1.158 |
| 52-Week Change | 512.89% |
| S&P500 52-Week Change | 18.32% |
| 52 Week High | 97.97 USD |
| 52 Week Low | 12.5 USD |
| 50-Day Moving Average | 76 USD |
| 200-Day Moving Average | 64.16 USD |
SLGL Share Statistics
| Avg. Volume (3 month) | 35.78K USD |
| Avg. Daily Volume (10-Days) | 50.5K USD |
| Shares Outstanding | 3.25M |
| Float | 530.07K |
| Short Ratio | 1.62 |
| % Held by Insiders | 59.70% |
| % Held by Institutions | 37.36% |
| Shares Short | 46.65K |
| Short % of Float | 4.42% |
| Short % of Shares Outstanding | 1.42% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -5.66% |
| Operating Margin (ttm) | -3569.44% |
| Gross Margin | 9.30% |
| EBITDA Margin | -12.45% |
Management Effectiveness
| Return on Assets (ttm) | -3.47% |
| Return on Equity (ttm) | -2.92% |
Income Statement
| Revenue (ttm) | 18.47M USD |
| Revenue Per Share (ttm) | 6.6 USD |
| Quarterly Revenue Growth (yoy) | -89.50% |
| Gross Profit (ttm) | 1.72M USD |
| EBITDA | -2300000 USD |
| Net Income Avi to Common (ttm) | -1046000 USD |
| Diluted EPS (ttm) | -0.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 52.83M USD |
| Total Cash Per Share (mrq) | 16.16 USD |
| Total Debt (mrq) | 862K USD |
| Total Debt/Equity (mrq) | 1.68 USD |
| Current Ratio (mrq) | 8.837 |
| Book Value Per Share (mrq) | 15.725 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Sol-Gel
| Country | United States |
| State | N/A |
| City | Ness Ziona |
| Address | 7 Golda Meir Street |
| ZIP | 7403650 |
| Phone | 972 8 931 3433 |
| Website | https://www.sol-gel.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Q&A For Sol-Gel Stock
What is a current SLGL stock price?
Sol-Gel SLGL stock price today per share is 81.99 USD.
How to purchase Sol-Gel stock?
You can buy SLGL shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sol-Gel?
The stock symbol or ticker of Sol-Gel is SLGL.
Which industry does the Sol-Gel company belong to?
The Sol-Gel industry is Biotechnology.
How many shares does Sol-Gel have in circulation?
The max supply of Sol-Gel shares is 3.25M.
What is Sol-Gel Price to Earnings Ratio (PE Ratio)?
Sol-Gel PE Ratio is now.
What was Sol-Gel earnings per share over the trailing 12 months (TTM)?
Sol-Gel EPS is -0.3 USD over the trailing 12 months.
Which sector does the Sol-Gel company belong to?
The Sol-Gel sector is Healthcare.
Sol-Gel SLGL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25913.9 USD — |
+2.13
|
10.13B USD — | 25420.35 USD — | 25967.44 USD — | — - | 10.13B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2235.3 USD — |
+1.88
|
— — | 2184.88 USD — | 2238.45 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1241.31 USD — |
+0.58
|
— — | 1233.81 USD — | 1244.91 USD — | — - | — — |
- {{ link.label }} {{link}}
